Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor

被引:20
作者
Sun, Nian-Kang [1 ,2 ]
Huang, Shang-Lang [1 ]
Lu, Hsing-Pang [1 ]
Chang, Ting-Chang [3 ]
Chao, Chuck C. -K. [1 ,4 ]
机构
[1] Chang Gung Univ, Coll Med, Dept Biochem & Mol Biol, Taoyuan, Taiwan
[2] Chang Gung Univ Sci & Technol, Div Biomed Sci, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan
[4] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan
关键词
androgen receptor; taxol; ovarian cancer; transcription factor; multiple drug resistance; PROSTATE-CANCER; PROGESTERONE-RECEPTOR; MEMBRANE TRANSPORTERS; 3-KINASE/AKT PATHWAY; INDUCED APOPTOSIS; ANTICANCER DRUGS; ABC TRANSPORTERS; EPITHELIAL-CELLS; BREAST-CANCER; GROWTH-FACTOR;
D O I
10.18632/oncotarget.4824
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A systematic analysis of the genes involved in taxol resistance (txr) has never been performed. In the present study, we created txr ovarian carcinoma cell lines to identify the genes involved in chemoresistance. Transcriptome analysis revealed 1,194 overexpressed genes in txr cells. Among the upregulated genes, more than 12 cryptic transcription factors were identified using MetaCore analysis (including AR, C/EBP beta, ERa, HNF4a, c-Jun/AP-1, c-Myc, and SP-1). Notably, individual silencing of these transcription factors (except HNF4 alpha) sensitized txr cells to taxol. The androgen receptor (AR) and its target genes were selected for further analysis. Silencing AR using RNA interference produced a 3-fold sensitization to taxol in txr cells, a response similar to that produced by silencing abcb1. AR silencing also downregulated the expression of prominent txr gene candidates (including abcb1, abcb6, abcg2, bmp5, fat3, fgfr2, h1f0, srcrb4d, and tmprss15). In contrast, AR activation using the agonist DHT upregulated expression of the target genes. Individually silencing seven out of nine (78%) AR-regulated txr genes sensitized txr cells to taxol. Inhibition of AKT and JNK cellular kinases using chemical inhibitors caused a dramatic suppression of AR expression. These results indicate that the AR represents a critical driver of gene expression involved in txr.
引用
收藏
页码:27065 / 27082
页数:18
相关论文
共 44 条
[1]   B-cell-derived lymphotoxin promotes castration-resistant prostate cancer [J].
Ammirante, Massimo ;
Luo, Jun-Li ;
Grivennikov, Sergei ;
Nedospasov, Sergei ;
Karin, Michael .
NATURE, 2010, 464 (7286) :302-U187
[2]   AN IMMUNOHISTOCHEMICAL EVALUATION OF ANDROGEN AND PROGESTERONE RECEPTORS IN OVARIAN-TUMORS [J].
CHADHA, S ;
RAO, BR ;
SLOTMAN, BJ ;
VANVROONHOVEN, CCJ ;
VANDERKWAST, TH .
HUMAN PATHOLOGY, 1993, 24 (01) :90-95
[3]  
CHAO CCK, 1991, CANCER RES, V51, P601
[4]   Structural basis for the nuclear import of the human androgen receptor [J].
Cutress, Mark L. ;
Whitaker, Hayley C. ;
Mills, Ian G. ;
Stewart, Murray ;
Neal, David E. .
JOURNAL OF CELL SCIENCE, 2008, 121 (07) :957-968
[5]   Castration-resistant prostate cancer: Adaptive responses in the androgen axis [J].
Egan, Alison ;
Dong, Yan ;
Zhang, Haitao ;
Qi, Yanfeng ;
Balk, Steven P. ;
Sartor, Oliver .
CANCER TREATMENT REVIEWS, 2014, 40 (03) :426-433
[6]  
Evangelou A, 2000, CANCER RES, V60, P929
[7]   ABC transporters in cancer: more than just drug efflux pumps [J].
Fletcher, Jamie I. ;
Haber, Michelle ;
Henderson, Michelle J. ;
Norris, Murray D. .
NATURE REVIEWS CANCER, 2010, 10 (02) :147-156
[8]  
Gao LN, 2013, PLOS ONE, P8
[9]   Multidrug resistance in cancer: Role of ATP-dependent transporters [J].
Gottesman, MM ;
Fojo, T ;
Bates, SE .
NATURE REVIEWS CANCER, 2002, 2 (01) :48-58
[10]   Pharmacologic Inhibition of Jak2-Stat5 Signaling By Jak2 Inhibitor AZD1480 Potently Suppresses Growth of Both Primary and Castrate-Resistant Prostate Cancer [J].
Gu, Lei ;
Liao, Zhiyong ;
Hoang, David T. ;
Dagvadorj, Ayush ;
Gupta, Shilpa ;
Blackmon, Shauna ;
Ellsworth, Elyse ;
Talati, Pooja ;
Leiby, Benjamin ;
Zinda, Michael ;
Lallas, Costas D. ;
Trabulsi, Edouard J. ;
McCue, Peter ;
Gomella, Leonard ;
Huszar, Dennis ;
Nevalainen, Marja T. .
CLINICAL CANCER RESEARCH, 2013, 19 (20) :5658-5674